News•Feb 24, 2026
Will AI Solve Immunology’s Debate Over “Self Vs. Non-Self?”
The article revisits the long‑standing self‑versus‑non‑self paradigm in immunology, highlighting fetal immune tolerance as a natural exception. It explains how maternal‑fetal microchimerism and epigenetic plasticity challenge traditional dogma and could unlock new treatments for auto‑immune disease, cancer, and age‑related inflammation. Leading researchers argue that integrating microbiome insights will reshape the field. The piece concludes that artificial intelligence, championed by Anthropic CEO Dario Amodei, may accelerate these breakthroughs by handling the complexity of immune data.
